Total net assets ($CAD):
$190.99 million

The top 15 holdings make up 69.69% of the Fund.
US Equity
International Equity
Cash and Equivalents
Canadian Equity
Other
United States
Japan
Germany
United Kingdom
France
Canada
Switzerland
Other
Singapore
Netherlands
Healthcare
Consumer Services
Financial Services
Real Estate
Cash and Cash Equivalent
Other
Top holdings Sector allocation (%)
Intercept Pharmaceuticals Inc Drugs 7.82%
SeaSpine Holdings Corp Diversified Healthcare 5.77%
Takeda Pharmaceutical Co Ltd Drugs 5.40%
Bristol-Myers Squibb Co Drugs 5.35%
CVS Health Corp Retail 5.23%
Biogen Idec Inc Drugs 5.21%
Alexion Pharmaceuticals Inc Drugs 5.15%
Astellas Pharma Inc Drugs 5.10%
GlaxoSmithKline PLC Drugs 3.94%
Ionis Pharmaceuticals Inc Drugs 3.60%
Merit Medical Systems Inc Drugs 3.59%
Trupanion Inc Insurance 3.59%
Fresenius Medical Care AG & Co KGaA Healthcare Services 3.57%
Sanofi SA Drugs 3.24%
Sangamo BioSciences Inc Diversified Healthcare 3.13%
Asset allocation

US Equity 62.48%

International Equity 34.12%

Cash and Equivalents 1.91%

Canadian Equity 1.48%

Other 0.01%

Geographic allocation

United States 62.91%

Japan 13.23%

Germany 5.76%

United Kingdom 5.63%

France 3.24%

Canada 2.96%

Switzerland 2.14%

Other 1.55%

Singapore 1.38%

Netherlands 1.20%

Sector allocation

Healthcare 84.53%

Consumer Services 7.96%

Financial Services 3.59%

Real Estate 2.00%

Cash and Cash Equivalent 1.91%

Other 0.01%